PCSA Processa Pharmaceuticals, Inc.
1.420USD-6.58%Mkt Cap: 3.97M $P/E: —1d ago
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.27BUSDP/E 30.7
$22.99BUSDP/E 14.5
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap3.97M USD
Enterprise Value4.05M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-13.56M USD
Revenue/Share—
Last Price1.420 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.41
PEG—
EV/EBITDA-0.32
EV/Revenue—
P/S—
P/B-13.33
EPS (TTM)-4.36
EPS (Forward)-3.75
52W Range
1.4100% of range14.25
52W High14.25 USD
52W Low1.410 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-243.20%
ROA-173.59%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.39M USD
CapEx (TTM)850.00K USD
FCF Margin—
FCF Yield-220.22%
Net Debt-196.32K USD
Net Debt/EBITDA0.02
Balance Sheet
Debt/Equity0.00
Current Ratio0.87
Quick Ratio0.08
Book Value/Sh-0.11 USD
Cash/Share0.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 23, 2019
Splits
Last Split1:25
Split DateDec 17, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.79M
Float2.70M
Insiders14.82%
Institutions18.70%
Short Interest
Short Ratio0.5d
Short % Float0.63%
Short % Out.0.54%
Shares Short14.99K
Short (prev mo.)67.32K
Technical
SMA 502.087 (-32.0%)
SMA 2002.537 (-44.0%)
Beta1.20
S&P 52W Chg16.45%
Avg Vol (30d)28.18K
Avg Vol (10d)24.64K
Technical Indicators
RSI (14)28.6
MACD-0.1737
MACD Signal-0.1407
MACD Hist.-0.0330
BB Upper2.226 USD
BB Middle1.815 USD
BB Lower1.404 USD
BB Width45.26%
ATR (14)0.1480 USD
Vol Ratio (20d)0.48x